Paxman AB (SE0009806284) — research page
SE · se-cm-kg/SSME/SE0009806284 · as of 2026-11-06
Identity and listing
Paxman AB is listed on First North Sweden under ticker SE0009806284, ISIN SE0009806284 and LEI 549300OT2V7Q4IDX8X68. Its security type, segment, sector and jurisdiction are not on the record. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | Paxman AB | source · 2026-11-06 |
| exchange | First North Sweden | source · 2026-11-06 |
| ticker | SE0009806284 | source · 2026-11-06 |
| ISIN | SE0009806284 | source · 2026-11-06 |
| LEI | 549300OT2V7Q4IDX8X68 | source · 2026-11-09 |
| security type | not on the record | |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | not on the record | |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 24 filings in the twelve months to 2026-11-06, across 21 filing days. Filings by type are: Investor News 17, Interim report (Q1 and Q3) 2, and one each of Annual financial report, Decisions of general meeting, Financial statement release, Half year financial report and Notice to general meeting. The median gap between filing days is 7.0 days, against a First North Sweden median of 11.0 days across 325 issuers. Days from the latest filing to the record date are 0, against a First North Sweden median of 7 days. The latest filing is dated 2026-11-06 and is of type Investor News. The sector median is not on the record.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 24 | 7 | 0 |
| exchange median: First North Sweden (325 issuers) | 21 | 11 | 7 |
| date | type | category | filing |
|---|---|---|---|
| 2026-11-06 | Investor News | Investor News | Invitation: Presentation with Richard Paxman - Q3 2026 |
| 2026-11-04 | Investor News | Investor News | Paxman Announces Official Commercial Launch of First-of-Its-Kind Neuropathy System as Scientific Evidence Highlights Significant Unmet Need in Chemotherapy-Induced Peripheral Neuropathy (CIPN) |
| 2026-10-30 | Investor News | Investor News | Paxman Secures First UK Orders for Neuropathy System Ahead of Commercial Launch to Address the Significant Unmet Clinical Need of Chemotherapy-Induced Peripheral Neuropathy (CIPN) |
| 2026-09-28 | Investor News | Investor News | California Enacts Landmark Scalp Cooling Coverage Legislation |
| 2026-08-21 | Half year financial report | Half year financial report | PAXMAN publishes its interim report for Q2 2026 |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record and its location are not on the record. The market's record does not carry auditor changes.
Events and halts
The record does not carry listing, delisting, name change, domicile change or segment move events, because no lifecycle type map exists for this register. The halt flag shows listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.
rule acm-68000/se/mifid-ii-product-governance/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations pages read.
Open research
No openly published research notes were found on the record.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The market's vintage is not sealed. No sealed years hold the issuer, and no earliest sealed date or live-record start date is on the record.
Sources
6 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://firds.esma.europa.eu/firds/ (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.3
- https://mcp.se-cm-kg.ai/events/SSME/SE0009806284 (the disclosure lines)
- 10.4
- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)
- 10.5
- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.6
- https://mcp.se-cm-kg.ai/record/SSME/SE0009806284 (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"SE0009806284"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:d93e5cc911e64274.